{"id":100173,"date":"2025-08-21T20:26:06","date_gmt":"2025-08-21T20:26:06","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/100173\/"},"modified":"2025-08-21T20:26:06","modified_gmt":"2025-08-21T20:26:06","slug":"what-are-glp-1s-all-on-medication-serena-williams-used-to-shed-30-lbs-trending","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/100173\/","title":{"rendered":"What are GLP-1s? All on medication Serena Williams used to shed 30 lbs | Trending"},"content":{"rendered":"\n

Serena Williams<\/a> recently revealed that she has been taking GLP<\/a>-1 agonists, a weight-loss medication <\/a>prescribed by Ro, to lose over 31 pounds. She also launched a campaign with the digital health company and telehealth platform to normalize the use of GLP-1 medicines for weight loss purposes, calling it \u201cscience.\u201d<\/p>\n

\"All All about GLP-1 drug.(Instagram\/serenawillaims) <\/p>\n

After giving birth to her daughters, Olympia and Adira, the four-time Olympic Gold medalist struggled with weight loss. \u201cI just couldn\u2019t get my weight to where I needed to be at a healthy place, and believe me, I don\u2019t take shortcuts,\u201d Williams said on TODAY.<\/p>\n

She changed her diet and maintained a strict workout regimen. But since there were no results, Williams turned to GLP-1 medicines.<\/p>\n

What are GLP-1 agonists?<\/p>\n

According to the Cleaveland Clinic, GLP-1 agonists (glucagon-like peptide-1 receptor agonists) are injectable medications used to treat Type 2 diabetes and obesity. They help in managing blood sugar (glucose) levels in people. There are seven types of GLP-1 agonists currently available in the US: Dulaglutide, Exenatide, Exenatide extended-release, Liraglutide, Lixisenatide, Semaglutide injection, and Semaglutide tablets.<\/p>\n

Exenatide was the first GLP-1 agonist to receive FDA (US Food and Drug Administration ) approval in 2005.<\/p>\n

Also read: Serena Williams reveals she lost 31 pounds, admits to using weight loss drugs: \u2018A really good decision\u2026’<\/a><\/p>\n

How does a GLP-1 agonist work?<\/p>\n

GLP-1 receptor agonists mimic the function of the GLP-1 hormone that is found in the gastrointestinal tract. GLP-1 agonists trigger insulin release from the pancreas, lowering the amount of glucose in the blood. If need be, GLP-1 agonists can also block the secretion of glucagon, a hormone that raises blood sugar levels. Additionally, GLP-1 agonists delay the digestion process, leading to appetite reduction.<\/p>\n

Are there side effects to using GLP-1 agonists?<\/p>\n

According to Harvard Health, GLP-1 agonists can cause Ozempic face, a condition that causes ugly wrinkles on the face.<\/p>\n

FAQsHow much weight has Serena Williams lost with GLP-1 agonists?<\/p>\n

Serena Williams claims to have lost over 30 pounds with GLP-1 agonists.<\/p>\n

What do GLP-1 agonists mainly treat?<\/p>\n

GLP-1 agonists mainly treat Type 2 diabetes or obesity.<\/p>\n

What does Serena Williams want to do with Ro?<\/p>\n

With Ro, Serena Williams wants to normalize the usage of GLP-1 agonists for weight loss purposes.<\/p>\n

What was the first GLP-1 agonist that the FDA approved?<\/p>\n

Exenatide was the first GLP-1 agonist that the FDA approved in 2005.<\/p>\n","protected":false},"excerpt":{"rendered":"Serena Williams recently revealed that she has been taking GLP-1 agonists, a weight-loss medication prescribed by Ro, to…\n","protected":false},"author":2,"featured_media":100174,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[58],"tags":[21952,3436,67114,97,243,986,3629,3458],"class_list":{"0":"post-100173","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-fda-approval","9":"tag-glp-1","10":"tag-glp-1-agonists","11":"tag-health","12":"tag-medication","13":"tag-obesity","14":"tag-type-2-diabetes","15":"tag-weight-loss"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/100173","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=100173"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/100173\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/100174"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=100173"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=100173"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=100173"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}